Trials / Completed
CompletedNCT03408041
Reported Time Between Onset and Diagnosis of Alzheimer's Disease: Correlation With Objective Parameters
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 129 (actual)
- Sponsor
- Murielle Surquin · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The early diagnosis of Alzheimer's disease is essential to enable patients to have access to the available treatments. However, there is a delay between the diagnosis and the onset of symptoms, which can range from 1 year to more than 5 years. In clinical practice, the hippocampal volume, measured by the Scheltens index, is currently used as a marker of the progression of the disease. The purpose of this study is to determine whether the patient's sex, age and ethnicity can influence the delay in the expression of cognitive troubles reported by the family at the first medical consultation, as well as to determine if there is a correlation between the delay reported by the family and the Scheltens index.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Medical file data extraction | Medical file data extraction |
Timeline
- Start date
- 2016-05-01
- Primary completion
- 2017-10-01
- Completion
- 2017-10-01
- First posted
- 2018-01-23
- Last updated
- 2018-01-23
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT03408041. Inclusion in this directory is not an endorsement.